As a proof of principle, the development of MLN4294 (a small molecule inhibitor of NAE1, see Figure 2) has shown that CRL activity can be inhibited and its impact is very promising in arresting the growth of many cancer cell lines as well as in vivo models of solid tumors [13]. This evidence concerns the gene IL31RA and cancer.